Core Viewpoint - The stock market opened positively in 2026, with New China Life Insurance leading the insurance sector with an 8.87% increase, marking a historical high in its A-share market value, surpassing 236.7 billion yuan [1][11]. Financial Performance - As of the end of Q3 2025, New China Life Insurance's total assets exceeded 1.8 trillion yuan, with premiums reaching 172.7 billion yuan, a year-on-year increase of 19% [4][14]. - The company's profit for the same period was 32 billion yuan, showing a significant increase of 119 million yuan compared to the previous year, with net profit for the first three quarters surpassing the total annual profit of previous years [4][14]. - The first-year premium income from long-term insurance reached 54.6 billion yuan, up 59.8% year-on-year, while the first-year regular premium income increased by 41% to 34.9 billion yuan [4][14]. Growth Drivers - The bank insurance channel has been a crucial growth point, with first-year premium income from this channel rising by 66.7% to 35.9 billion yuan [4][14]. - New business value increased by 50.8%, and renewal premiums remained stable, indicating strong growth across various business metrics [4][14]. Claims and Social Responsibility - In 2025, New China Life Insurance processed 5.01 million claims, with total payouts amounting to 14.7 billion yuan, averaging over 10,000 claims per day [4][14]. - The company has actively engaged in inclusive finance and supported numerous large-scale public welfare projects, with total payouts exceeding 3.3 billion yuan for rural populations [6][16]. Market Recognition - The stock price increase reflects the capital market's high recognition of New China Life Insurance's long-term value, with over ten securities institutions giving a "buy" rating in the last three months [8][20]. - The company has received multiple accolades, including being listed among the Fortune Global 500 and ranking among the top 50 global life insurance companies [20]. Innovation and Technology - New China Life Insurance focuses on product innovation, creating a comprehensive product system that addresses customer needs across various life stages, including health protection and wealth management [9][19]. - The company plans to invest at least 3 billion yuan in artificial intelligence and big data over the next 3-5 years to enhance its digital capabilities [9][19]. Investment Performance - The annualized investment return rate for the first three quarters of 2025 was 8.6%, with an average total investment return rate exceeding 5% over the past decade, positioning the company among market leaders [10][20].

Core Insights - The insurance industry is shifting focus towards participating insurance products due to declining market interest rates, with guaranteed rates for fixed income products at 2% and for participating products at 1.75%, resulting in a narrow 0.25% rate difference [2][22] - The "old seven" major insurance companies in mainland China have launched a total of 15 participating whole life insurance products this year, with Taiping Life Insurance offering the most at five products, while the others offer one to two products each [2][22] - The highest illustrated rates among these products are 3.75% for Taiping's Xinfu Xiangban Chuan Shi version and 3.9% for Xinhua's Shengshi Rongyao Qingtian version, with most others around 3.5% [2][22] Group 1: Product Performance Analysis - In the case of single premium payments, the top three products based on guaranteed cash value performance are Taiping's Xinfu Xiangban Chuan Shi version, Xinhua's Shengshi Rongyao Qingtian version, and China Life's Xin Yue Chuan Jia Qingtian version [3][23] - For five-year premium payments, the leading products in terms of guaranteed cash value are Taiping's Xinfu Xiangban Chuan Shi version, Xinhua's Shengshi Rongyao Qingtian version, and Taikang's Le Zeng Shou Qingtian version [8][10] - Under six-year premium payments, the top three products are China Life's Xin Yue Chuan Jia Qingtian version, Renbao's Fu Lu Man Tang 2025, and Taikang's Xin Xiang Shi Jia 2026 [12][14] - For ten-year premium payments, the best performing products are Taiping's Xinfu Xiangban Chuan Shi version, Renbao's Fu Lu Man Tang 2025, and Ping An's Yu Xiang Jin Yue 2026 [16][18] Group 2: Long-term Value Considerations - The performance of products with higher illustrated rates does not necessarily translate to better actual cash value, emphasizing the importance of evaluating specific numerical data [19] - Taiping Life Insurance has shown significant improvements in its product offerings, actively embracing the internet and launching numerous participating whole life insurance products, establishing a notable advantage among the "old seven" [19] - The dividend realization rates have improved for Ping An, China Life, and Taiping, with Taiping's new products demonstrating generous illustrated data, while China Life and Ping An maintain a conservative approach [19]